{
    "clinical_study": {
        "@rank": "40116", 
        "acronym": "SHINY", 
        "arm_group": [
            {
                "arm_group_label": "conbercept treatment group", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will receive conbercept injections at a dose of 0.5 mg/eye, once a month for first 3 months. In the next 6 months, the investigator will decide whether repeat injections are needed base on the monthly assessment results."
            }, 
            {
                "arm_group_label": "sham injection group", 
                "arm_group_type": "Sham Comparator", 
                "description": "Subjects will receive sham injections monthly for 3 months and will receive 0.5 mg/eye conbercept at month 4. The investigator will decide whether repeat injections are needed base on the monthly assessment results from month 5 to month 9."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is design to evaluate the effect of conbercept therapy on visual acuity and\n      anatomic outcomes compared to sham injection and durability of response observed in subjects\n      with choroid neovascularization secondary to pathological myopia."
        }, 
        "brief_title": "A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Choroid Neovascularization Secondary to Degenerative Myopia", 
        "condition_browse": {
            "mesh_term": [
                "Myopia", 
                "Neovascularization, Pathologic", 
                "Myopia, Degenerative", 
                "Choroidal Neovascularization"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients give fully informed consent and are willing and able to comply with all\n             study procedures.\n\n          2. In the study eye:\n\n               -  Myopia of equal to or greater than -6.00D,and axial length \u226526.5mm.\n\n               -  Diagnosis of active subfoveal, juxafoveal, or extrafoveal CNV secondary to high\n                  myopia.\n\n               -  Visual impairment due to CNV secondary to high myopia.\n\n               -  BCVA score \u226524 and \u226473 ETDRS letters (approximately 20/40~ 20/320 Snellen\n                  equivalent).\n\n               -  Ocular media of sufficient quality to obtain fundus and OCT images.\n\n          3. The BCVA score of fellow eyes \u2265 19 ETDRS letters (approximately 20/400 Snellen\n             equivalent)\n\n        Exclusion Criteria:\n\n          1. Current vitreous hemorrhage in either eye.\n\n          2. Intraocular treatment with corticosteroids within last 3 months or periocular\n             treatment with corticosteroids within last month in the study eye.\n\n          3. Active infectious ocular inflammation in either eye.\n\n          4. Fibrosis or atrophy involving the center of foveal in the study eye.\n\n          5. Any concurrent intraocular condition in the study eye that, in the opinion of\n             investigator, could either require medical or surgical intervention during the study\n             period to prevent or treat visual loss that might result from that condition.\n\n          6. The lesion size \u226530 mm2 in the study eye.\n\n          7. Any ocular disorder in the study eye that, in the opinion of the investigator, may\n             confound interpretation of the study results.\n\n          8. Uncontrolled glaucoma or cup/disk ratio > 0.8 in the study eye.\n\n          9. Aphakia (excluding artificial lens) in the study eye.\n\n         10. Serious amblyopia and amaurosis in the fellow eye."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "176", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01809223", 
            "org_study_id": "KHSWKH902007"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "conbercept treatment group", 
                    "sham injection group"
                ], 
                "description": "intravitreal injection of 0.5 mg conbercept per month, fixed injection", 
                "intervention_name": "conbercept, Fixed", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "conbercept treatment group", 
                    "sham injection group"
                ], 
                "description": "intravitreal injection of 0.5 mg conbercept as need, PRN", 
                "intervention_name": "conbercept, PRN", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "sham injection group", 
                "description": "sham intravitreal injection per month, fixed injection", 
                "intervention_name": "sham injection", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100730"
                    }, 
                    "name": "Beijing Tongren hospital affiliated to Capital Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100083"
                    }, 
                    "name": "Peking University Third Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100032"
                    }, 
                    "name": "Peking Union Medical College Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Chongqing", 
                        "zip": "400042"
                    }, 
                    "name": "Daping Hospital, Research Institute of Surgery Third Military Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Chongqing", 
                        "zip": "400038"
                    }, 
                    "name": "Southwest Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510060"
                    }, 
                    "name": "Zhongshan Ophthalmic Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430070"
                    }, 
                    "name": "Wuhan General Hospital of Guangzhou Military"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuxi", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "214002"
                    }, 
                    "name": "Wuxi No.2 People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Qingdao", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "266071"
                    }, 
                    "name": "Ophthalmologic Hospital of Qingdao"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200080"
                    }, 
                    "name": "Shanghai First People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Xian", 
                        "country": "China", 
                        "state": "Shanxi", 
                        "zip": "710032"
                    }, 
                    "name": "Xijing Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610041"
                    }, 
                    "name": "West China Hospital of Sichuan University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wenzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "325027"
                    }, 
                    "name": "The Affiliated Eye Hospital of WMC"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Safety and Efficacy of Conbercept in the Treatment of Choroidal Neovascularization (CNV) Secondary to High Myopia", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "to compare the mean change from baseline of best-corrected visual acuity (BCVA) between conbercept treatment group and sham injection group at month 3", 
            "measure": "mean change from baseline of visual acuity", 
            "safety_issue": "No", 
            "time_frame": "3-month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01809223"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "to compare the difference of mean change from baseline of CRT, CNV size and lesion size between conbercept treatment group and sham injection group at month 3", 
                "measure": "mean change from baseline of anatomical features", 
                "safety_issue": "No", 
                "time_frame": "3-month"
            }, 
            {
                "description": "to evaluate the mean change from baseline of BCVA of two groups from month 1 to month 9", 
                "measure": "mean change from baseline of visual acuity", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "description": "to evaluate the incidence of AEs (ocular or non-ocular) of two groups at month 3 and 9", 
                "measure": "safety and tolerability of conbercept", 
                "safety_issue": "Yes", 
                "time_frame": "3-month and 9-month"
            }
        ], 
        "source": "Chengdu Kanghong Biotech Co.,Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chengdu Kanghong Biotech Co.,Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}